4Hu OY. Ftang HS, Chang CL. Influence of chronic loboular hepatitis on pharmacokinetics of cefoperazone a novel galactose sigle point method as a measure of residual liver ruction[J]. Biopham Drug Dispos, 1994, 15(7):563.
8Harold C. Safety of cefepime :a new extended-spectrum parenteral cephalosporin. Am J Med,1996,100(Suppl 6A) :68s-75s.
9Comely OA, Bethe U, Seifert H, et al. A randomized monocentric trial in febrile neutropen patients:ceftriaxone and gentamicin vs cdepime and gentamicin. Ann Hemato1,2002 ,81:37-43.
10Egerer G, Goldschwidt H, Streich N, et al. Cegtutidinm in combination with glycopeptide antibiotic is an effetive first-fine therapy for patients undergoing hige-dose therapy with autologous peripheral blood stem cell support. Support Care Cancer, 1999,7:336-342.
